TGFB1 and fibrosis: In this scenario, Sadasivan et al. [35] developed a fibrosis model using PCLSs treated with a fibrogenic cocktail composed of TGF-β, platelet-derived growth factor, lysophosphatidic acid, sphingosine-1-phosphate, lipopolysaccharide, and palmitate.